Results

eNauka >  Results >  Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial
Title: Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial
Authors: Blay, Jean-Yves; Pápai, Zsuzsanna; Tolcher, Anthony W; Italiano, Antoine; Cupissol, Didier; López-Pousa, Antonio; Chawla, Sant P; Bompas, Emmanuelle; Babović, Nada ; Penel, Nicolas;
Isambert, Nicolas; Staddon, Arthur P; Saâda-Bouzid, Esma; Santoro, Armando; Franke, Fabio A; Cohen, Patrick; Le-Guennec, Solenn; Demetri, George D;
Issue Date: 2015
Publication: The Lancet Oncology
ISSN: 1470-2045 Lancet Oncology Search Idenfier
Publisher: London : Lancet Pub. Group
Type: Article
Collation: vol. 16 br. 5 str. 531-540
DOI: 10.1016/s1470-2045(15)70102-6
WoS-ID: 000353908200047
Scopus-ID: 2-s2.0-84933678829
URI: https://enauka.gov.rs/handle/123456789/190781
URL: https://www.sciencedirect.com/science/article/abs/pii/S1470204515701026
Metadata source: Migrirano iz RIS podataka
M-category: 
21a+M21a+

65
SCOPUSTM
47
OpenCitations
60
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.